Crushmetric Group Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG613521031
GBP
0.10
-0.02 (-20.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Crushmetric Group Ltd. stock-summary
stock-summary
Crushmetric Group Ltd.
Pharmaceuticals & Biotechnology
MiLOC Group Limited is a United Kingdom-based holding company of a group engaged in the provision of traditional Chinese medicine (TCM) healthcare services, including consultations and TCM therapies, through a network of clinics in Hong Kong, and the sale and distribution of TCM healthcare and skincare products through wholesale outlets and TCM clinics, its retail store in Hong Kong and other non-related TCM retail stores, as well as directly to customers through its online store. It operates through two business segments: Sales of TCM and healthcare and skincare products, and Provision of TCM healthcare services. Its Rorrico is a TCM product for the treatment of influenza viruses, including the Influenza A virus and its sub-type virus, pandemic H1N1 or Swine flu. Rorrico's formula contains approximately 20 herbs. It is confected with honeysuckle, radix isatidis, rhubarb, codonopsis pilosula, amomum villosum, malt and white atractylodes medicine.
Company Coordinates stock-summary
Company Details
Unit 02, 21/F, Bayfield Building,, 99 Hennessy Road, Wanchai NA None : None
stock-summary
Tel: 852 21104221
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Dr. Ching Fung Chow
Executive Chairman of the Board
Mr. Ban Poh Ong
Executive Director
Shrago Colin
Non-Executive Independent Director
Mr. Kian Jing Ow
Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

-17.27%

stock-summary
Price to Book

0.00